[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT1056458E - Tratamento de dor cronica - Google Patents

Tratamento de dor cronica

Info

Publication number
PT1056458E
PT1056458E PT99936030T PT99936030T PT1056458E PT 1056458 E PT1056458 E PT 1056458E PT 99936030 T PT99936030 T PT 99936030T PT 99936030 T PT99936030 T PT 99936030T PT 1056458 E PT1056458 E PT 1056458E
Authority
PT
Portugal
Prior art keywords
chronic pain
pain treatment
chronic
metanicotine
suffering
Prior art date
Application number
PT99936030T
Other languages
English (en)
Inventor
James C Eisenach
Original Assignee
Univ Wake Forest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest filed Critical Univ Wake Forest
Publication of PT1056458E publication Critical patent/PT1056458E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT99936030T 1998-02-24 1999-02-24 Tratamento de dor cronica PT1056458E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7579498P 1998-02-24 1998-02-24

Publications (1)

Publication Number Publication Date
PT1056458E true PT1056458E (pt) 2005-08-31

Family

ID=22128028

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99936030T PT1056458E (pt) 1998-02-24 1999-02-24 Tratamento de dor cronica

Country Status (13)

Country Link
US (1) US6248744B1 (pt)
EP (1) EP1056458B1 (pt)
JP (1) JP2002504512A (pt)
KR (2) KR20060085258A (pt)
AT (1) ATE293972T1 (pt)
AU (1) AU3308099A (pt)
BR (1) BR9908190A (pt)
CA (1) CA2321991A1 (pt)
DE (1) DE69924979T2 (pt)
ES (1) ES2242405T3 (pt)
MX (1) MXPA00008273A (pt)
PT (1) PT1056458E (pt)
WO (1) WO1999043322A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6448276B1 (en) * 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
WO2003022261A1 (en) 2001-09-13 2003-03-20 Miller Kenneth E Method of alleviating pain
CA2392486A1 (en) 2002-07-05 2002-12-08 Duchesnay Inc. Pharmaceutical dosage form bearing pregnancy-friendly indicia
EP1587506B1 (en) * 2002-12-18 2008-07-23 Algorx Administration of capsaicinoids
US20050019436A1 (en) * 2002-12-18 2005-01-27 Algorx Injectable capsaicin
BRPI0409748A (pt) * 2003-04-08 2006-10-24 Algorx Pharmaceuticals Inc preparação e purificação de capsaicin sintetico
WO2007055928A1 (en) * 2005-11-03 2007-05-18 Targacept, Inc. 5-membered ring metanicotine analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5616716A (en) * 1996-01-06 1997-04-01 Dull; Gary M. (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds
US5861423A (en) * 1997-02-21 1999-01-19 Caldwell; William Scott Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
US5811442A (en) * 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow

Also Published As

Publication number Publication date
ES2242405T3 (es) 2005-11-01
AU3308099A (en) 1999-09-15
DE69924979T2 (de) 2006-01-19
WO1999043322A1 (en) 1999-09-02
ATE293972T1 (de) 2005-05-15
BR9908190A (pt) 2000-10-24
EP1056458B1 (en) 2005-04-27
KR20060085258A (ko) 2006-07-26
US6248744B1 (en) 2001-06-19
KR100703640B1 (ko) 2007-04-05
JP2002504512A (ja) 2002-02-12
MXPA00008273A (es) 2002-04-24
KR20010096465A (ko) 2001-11-07
DE69924979D1 (de) 2005-06-02
CA2321991A1 (en) 1999-09-02
EP1056458A1 (en) 2000-12-06
EP1056458A4 (en) 2001-06-20

Similar Documents

Publication Publication Date Title
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ATE303162T1 (de) Natrium kanalblocker zusammensetzungen und deren verwendung
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE207356T1 (de) Verwendung von tiagabin zur behandlung von schlafstörungen
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
DE69929464D1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
DE69814394D1 (de) Verwendung von levobupivacain
HK1051490A1 (en) Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs.
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
PT1056458E (pt) Tratamento de dor cronica
ATE296098T1 (de) Verwendung von topiramat zur behandlung und diagnostizierung von atemstörungen während des schlafens und mittel zur durchführung der behandlung und diagnose
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
ATE302011T1 (de) PONAZURIL ZUR BEHANDLUNG VON DURCH COCCIDIA NEUROLOGISCHEN UND ßABORTIGENICß VERURSACHTEN ERKRANKUNGEN
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
MY124071A (en) Treatment of viral disease in swine
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE545423T1 (de) Mittel zur behandlung von lungenkrebs
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
AUPP379698A0 (en) Using ngali nut oil to treat/relieve the pain of arthritis and other similar conditions
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
DE60024408D1 (de) Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen
NO20024545D0 (no) Fremgangsmåte for behandling av kongestiv hjertefeil
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
NO984198L (no) FremgangsmÕte for behandling av aggresjon
ATE319443T1 (de) Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n- dimethylglycin